news Engineered stem cells could evade immune system rejection, study shows 16 September 2020 | By Victoria Rees (Drug Target Review) By editing out a set of proteins on the surface of human pluripotent stem cells, researchers have ensured they will be not be rejected by the body's immune system.
news CRISPR technology can correct Alpha-1 antitrypsin deficiency 4 July 2018 | By Dr Zara Kassam (Drug Target Review) Groundbreaking research demonstrates proof-of-concept for using CRISPR-Cas9 genome editing technology to correct the gene mutation responsible for AAT deficiency...
news Nanoparticle aggregates for destruction of cancer cells 13 June 2017 | By Niamh Marriott (Drug Target Review) An international team has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.